Frontlight ResearchEarly access
Trial site
University Hospital Sveti Duh
- 9running trials
- 7closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis3 trials
- Epilepsy2 trials
- Sjögren's disease2 trials
- Asthma1 trial
- Atrial fibrillation1 trial
- Chronic lymphocytic leukaemia1 trial
- Hodgkin lymphoma1 trial
- IgA nephropathy1 trial
- Macular degeneration1 trial
- Multiple myeloma1 trial
- Osteoarthritis1 trial
- Primary biliary cholangitis1 trial
- and 1 more
- Phase
- Phase 311 trials
- Phase 23 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Completed7 trials
- Recruiting5 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Lead sponsor
- Biohaven Therapeutics Ltd.2 trials
- AbbVie1 trial
- Amgen1 trial
- Anthos Therapeutics, Inc.1 trial
- Arrowhead Pharmaceuticals1 trial
- and 10 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis2 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Hodgkin lymphoma1 recruiting
- Macular degeneration1 recruiting
- Multiple myeloma1 recruiting
- Osteoarthritis1 recruiting
- Primary biliary cholangitis1 recruiting
Closed trials
Completed
Enrolling by invitation
Completed
Completed
Active, not recruiting
Completed
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma
Completed
A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026